Scott A. Armstrong

40.4k citations

234 papers · 22.8k indexed · 9 hit papers · h-index 69

Impact in

Hematology top 0.05%
- Acute Myeloid Leukemia Research
Molecular Biology top 0.1%
- Epigenetics and DNA Methylation
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
- Genomics and Chromatin Dynamics
- Cancer-related gene regulation
- Bioinformatics and Genomic Networks

Papers in

Hematology 116
- Acute Myeloid Leukemia Research 104
- Chronic Myeloid Leukemia Treatments 15
Molecular Biology 182
- Protein Degradation and Inhibitors 62
- Epigenetics and DNA Methylation 60
- Genomics and Chromatin Dynamics 33
- Cancer-related gene regulation 27
- Histone Deacetylase Inhibitors Research 24

Co-authors: Andrei V. Krivtsov Todd R. Golub Stanley J. Korsmeyer Guo Wei Amit Sinha Stephen E. Sallan Lewis B. Silverman Eric S. Lander
Journals: Blood (71 papers)Cancer Cell (11 papers)Cancer Research (8 papers)Cell stem cell (7 papers)Clinical Cancer Research (6 papers)
Partner nations: United States Germany United Kingdom

In The Last Decade

Scott A. Armstrong

216 papers receiving 22.5k citations

Hit Papers

9 papers align trajectories log scale

Chromatin-modifying enzymes as modulators of reprogramming 2012 · 488 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2012 Nature
2011 Cancer Cell
2010 Science
2007 Cell
2007 Nature reviews. Cancer
2006 Cancer Cell
2006 Nature
2006 Science
2001 Nature Genetics

Peers

Countries citing papers authored by Scott A. Armstrong

Since Specialization

Citations

This map shows the geographic impact of Scott A. Armstrong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott A. Armstrong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott A. Armstrong more than expected).

Fields of papers citing papers by Scott A. Armstrong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott A. Armstrong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott A. Armstrong. The network helps show where Scott A. Armstrong may publish in the future.

Co-authors

The 25 scholars most cited alongside Scott A. Armstrong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Scott A. Armstrong Line = papers co-authored together Scott A. Armstrong links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	An in vivo barcoded CRISPR-Cas9 screen identifies Ncoa4-mediated ferritinophagy as a dependence in Tet2-deficient hematopoiesis Blood ·Justin Loke, Peter G. Kim, Thuy T. P. Nguyen, Meaghan Boileau, Marie McConkey, Aidan Miller, Wesley Shin, Christopher A. Hergott, Maria Ericsson, Anja E. H. Nordstrom, Paula Montero Llopis, Scott A. Armstrong, Joseph D. Mancias, Benjamin L. Ebert	2025	2
2	A MOZ-TIF2 leukemia mouse model displays KAT6-dependent H3K23 propionylation and overexpression of a set of active developmental genes Proceedings of the National Academy of Sciences ·Anne E. Smolko, Daniel Sullivan, Sarah Naomi Olsen, Heather A. Kang, Samuel D. Whedon, Jonathan B. Baell, Philip A. Cole, Scott A. Armstrong, Mitzi I. Kuroda	2024	5
3	Discerning the Landscape of Menin Inhibitor Resistance Blood ·Wallace Bourgeois, Jevon Cutler, Hannah E Rice, Brandon Regalado, Daniela V. Wenge, Florian Perner, John G. Doench, Jerry M McGeehan, Scott A. Armstrong	2024	6
4	HAND1 and BARX1 Act as Transcriptional and Anatomic Determinants of Malignancy in Gastrointestinal Stromal Tumor Clinical Cancer Research ·Matthew L. Hemming, Shannon Coy, Jia‐Ren Lin, Jessica L. Andersen, Joanna Przybył, Emanuele Mazzola, Amr H. Abdelhamid Ahmed, Matt van de Rijn, Peter K. Sorger, Scott A. Armstrong, George D. Demetri, Sandro Santagata	2021	17
5	Oncogenic Gene-Expression Programs in Leiomyosarcoma and Characterization of Conventional, Inflammatory, and Uterogenic Subtypes Molecular Cancer Research ·Matthew L. Hemming, Changyu Fan, Chandrajit P. Raut, George D. Demetri, Scott A. Armstrong, Ewa Sicińska, Suzanne George	2020	22
6	Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia Science ·Hannah J. Uckelmann, Stephanie M. Kim, Eric Wong, Charlie Hatton, Hugh Giovinazzo, Jayant Y. Gadrey, Andrei V. Krivtsov, Frank G. Rücker, Konstanze Döhner, Gerard M. McGeehan, Ross L. Levine, Lars Bullinger, George S. Vassiliou, Scott A. Armstrong	2020	152
7	Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and Are Targetable by BET Bromodomain Inhibition Cancer Research ·Matthew L. Hemming, Matthew A. Lawlor, Jessica L. Andersen, Timothy Hagan, Otari Chipashvili, Thomas G. Scott, Chandrajit P. Raut, Ewa Sicińska, Scott A. Armstrong, George D. Demetri, James E. Bradner	2019	21
8	A Phase Ib/II Study of the Histone Methyltransferase Inhibitor Pinometostat in Combination with Azacitidine in Patients with 11q23-Rearranged Acute Myeloid Leukemia Blood ·Kamal Menghrajani, Sheng F. Cai, Sean M. Devlin, Scott A. Armstrong, Richard Piekarz, Michelle A. Rudek, Martin S. Tallman, Eytan M. Stein	2019	12
9	Resistance Mechanisms to SYK Inhibition in Acute Myeloid Leukemia Cancer Discovery ·Anjali Cremer, Jana M. Ellegast, Gabriela Alexe, Elizabeth S. Frank, Linda S. Ross, S. Haihua Chu, Yana Pikman, Amanda L. Robichaud, Amy Goodale, Björn Häupl, Sebastian Mohr, Arati V. Rao, Alison R. Walker, James S. Blachly, Federica Piccioni, Scott A. Armstrong, John C. Byrd, Thomas Oellerich, Kimberly Stegmaier	2019	26
10	LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1- and C/EBPα-dependent enhancers in AML Blood ·Monica Cusan, Sheng F. Cai, Helai P. Mohammad, Andrei V. Krivtsov, Alan Chramiec, Evangelia Loizou, Matthew D. Witkin, Kimberly N. Smitheman, Daniel G. Tenen, Min Ye, Britta Will, Ulrich Steidl, Ryan G. Kruger, Ross L. Levine, Hugh Young Rienhoff, Richard P. Koche, Scott A. Armstrong	2018	81
11	Histone Acetyltransferase Activity of MOF Is Required for MLL-AF9 Leukemogenesis Cancer Research ·Daria G. Valerio, Haiming Xu, Chun‐Wei Chen, Takayuki Hoshii, Meghan E. Eisold, Christopher D. Delaney, Monica Cusan, Aniruddha J. Deshpande, Chun‐Hao Huang, Amaia Lujambio, Y. George Zheng, Johannes Zuber, Tej K. Pandita, Scott W. Lowe, Scott A. Armstrong	2017	35
12	Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia Cancer Discovery ·Michael W.M. Kühn, E Song, Zhaohui Feng, Amit Sinha, Chun‐Wei Chen, Aniruddha J. Deshpande, Monica Cusan, Noushin Farnoud, Annalisa Mupo, Carolyn Grove, Richard P. Koche, James E. Bradner, Elisa de Stanchina, George S. Vassiliou, Takayuki Hoshii, Scott A. Armstrong	2016	166
13	Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL Clinical Cancer Research ·Matthew C. Stubbs, Won-Il Kim, Megan Bariteau, Tina Davis, Sridhar Vempati, Janna Minehart, Matthew D. Witkin, Jun Qi, Andrei V. Krivtsov, James E. Bradner, Andrew L. Kung, Scott A. Armstrong	2015	59
14	Acute Myelogenous Leukemia-Induced Sympathetic Neuropathy Promotes Malignancy in an Altered Hematopoietic Stem Cell Niche Cell stem cell ·Maher Hanoun, Dachuan Zhang, Toshihide Mizoguchi, Sandra Pinho, Halley Pierce, Yuya Kunisaki, Julie Lacombe, Scott A. Armstrong, Ulrich Dührsen, Paul S. Frenette	2014	276
15	Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera Blood ·Ann Mullally, Claudia Bruedigam, Luke Poveromo, Florian H. Heidel, Amy S. Purdon, Therese Vu, Rebecca Austin, Dirk Heckl, Lawrence J. Breyfogle, Catherine Paine Kuhn, Demetrios Kalaitzidis, Scott A. Armstrong, David A. Williams, Geoffrey R. Hill, Benjamin L. Ebert, Steven Lane	2013	126
16	Common and Overlapping Oncogenic Pathways Contribute to the Evolution of Acute Myeloid Leukemias Cancer Research ·Brynn T. Kvinlaug, Wai-In Chan, Lars Bullinger, Mukundhan Ramaswami, Christopher Sears, Donna Foster, Stanley E. Lazic, Rachel Okabe, Axel Benner, Benjamin H. Lee, Inusha De Silva, Peter J.M. Valk, Ruud Delwel, Scott A. Armstrong, Hartmut Döhner, D. Gary Gilliland, Brian J.P. Huntly	2011	37
17	The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML Science ·Jenny Wang, Andrei V. Krivtsov, Amit Sinha, Trista E. North, Wolfram Goessling, Zhaohui Feng, Leonard I. Zon, Scott A. Armstrong Hit paper breakdown →	2010	564
18	MLL -Rearranged B Lymphoblastic Leukemias Selectively Express the Immunoregulatory Carbohydrate-Binding Protein Galectin-1 Clinical Cancer Research ·Przemysław Juszczyński, Scott J. Rodig, Jing Ouyang, Evan A. O’Donnell, Kunihiko Takeyama, Wojciech Młynarski, Katarzyna Mycko, Tomasz Szczepański, Anna Gaworczyk, Andrei V. Krivtsov, Joerg Faber, Amit Sinha, Gabriel A. Rabinovich, Scott A. Armstrong, Jeffery L. Kutok, Margaret A. Shipp	2010	28
19	Gene Expression Profiling Identifies BAX-δ as a Novel Tumor Antigen in Acute Lymphoblastic Leukemia Cancer Research ·Sara Maia, W. Nicholas Haining, Sascha Ansén, Zhinan Xia, Scott A. Armstrong, Nilufer P. Seth, Paolo Ghia, Monique L. den Boer, Rob Pieters, Stephen E. Sallan, Lee M. Nadler, Angelo A. Cardoso	2005	28
20	Genomic organization of the Papaver rhoeas self-incompatibility S1 locus Journal of Experimental Botany ·Michael Wheeler, Scott A. Armstrong, Vernonica E. Franklin‐Tong, F. Chris H. Franklin	2003	14

About Scott A. Armstrong

Scott A. Armstrong is a scholar working on Hematology, Molecular Biology, Genetics, Oncology and Public Health, Environmental and Occupational Health, having authored 234 papers that have together received 22.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (104 papers), Protein Degradation and Inhibitors (62 papers), Epigenetics and DNA Methylation (60 papers), Genomics and Chromatin Dynamics (33 papers), Acute Lymphoblastic Leukemia research (30 papers), Cancer-related gene regulation (27 papers), Histone Deacetylase Inhibitors Research (24 papers) and Chronic Myeloid Leukemia Treatments (15 papers). The work is most often cited by research in Hematology (6.9k citations), Molecular Biology (17.0k citations), Aging (288 citations), Genetics (1.7k citations) and Cancer Research (2.4k citations). Scott A. Armstrong has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Andrei V. Krivtsov, Todd R. Golub, Stanley J. Korsmeyer, Guo Wei, Amit Sinha, Stephen E. Sallan, Lewis B. Silverman, Eric S. Lander, Justin Lamb and Monique L. den Boer. Their work appears in journals such as Blood, Cancer Cell, Cancer Research, Cell stem cell and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact